Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com advises buying Divis Laboratories.
Vishal Malkan of malkansview.com advises buying NIIT with a target of Rs 107.
Rakesh Bansal of RK Global advises buying Ashoka Buildcon with a target of Rs 212.
According to Sudarshan Sukhani of s2analytics.com, one may buy Divis Laboratories.
Gaurav Bissa of LKP Securities advises buying ITC with a target of Rs 370.
Sudarshan Sukhani of s2analytics.com is of the view that one may buy Divis Laboratories.
Vishal Malkan of malkansview.com advises selling CESC with a target of Rs 540.
Amit Gupta of ICICIdirect is of the view that Divis Laboratories may test Rs 1280-1290.
Chandan Taparia of Anand Rathi Securities recommends buying Divis Laboratories for a target of Rs 1240.
SP Tulsian of sptulsian.com is of the view that one can look for target of Rs 520-525 in Atul Auto and more than Rs 1200 in Divis Labs.
CA Rudramurthy BV of Vachana Investments is of the view that one may buy Wonderla with a target of Rs 332.
Shubham Agarwal of Motilal Oswal Securities expects Divis Laboratories to test Rs 1210.
According to Aditya Agarwal of Way2Wealth Securities, one can sell Divis Labs with a target of Rs 1,040.
Hemen Kapadia of KRChoksey Securities is of the view that one may buy Bharat Forge with a target of Rs 964.
Kunal Bothra of LKP Securities recommends buying Divis Labs and SREI Infra.
Amit Gupta of ICICIdirect recommends buying Divis Laboratories as the stock may move towards Rs 1250-1270 in this series or the next series.
Pritesh Mehta of IIFL recommends buying Divis Labs and Oriental Bank of Commerce.
Sudarshan Sukhani of s2analytics.com is of the view that SKS Microfinance is worth buying into.
Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Divis Laboratories and Sun TV.
Sudarshan Sukhani of s2analytics.com recommends buying Asian Paints, Divis Laboratories and Tech Mahindra.
Manish Sharma of Destimoney Securities is of the view that one may buy Colgate Palmolive with a target of Rs 2015.
VK Sharma of HDFC Securities is of the view that one can buy Divis Laboratories 2,200 Call.
According to Sameet Chavan of Angel Broking, one may short Divis Laboratories for a target of Rs 2,040.
Sudarshan Sukhani of s2analytics.com is of the view that one may look at Divis Laboratories.
The companies mentioned in A-list are picks of CNBC-TV18's experts and not recommendations to buy.